T cell-prolymphocytic leukemia detected in a patient of breast cancer at the time of recurrence: a case report

[1]  K. Chang,et al.  Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  T. Robak,et al.  Current treatment options in prolymphocytic leukemia. , 2007, Medical science monitor : international medical journal of experimental and clinical research.

[3]  P. Fenaux,et al.  Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  B. Friedenson,et al.  The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers , 2007, BMC Cancer.

[5]  J. Bergh,et al.  Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Roy E. Smith.  Risk for the development of treatment-related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjuvant Breast and Bowel Project experience. , 2003, Clinical breast cancer.

[7]  D. Catovsky,et al.  High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. , 2001, Blood.

[8]  G. Hortobagyi,et al.  Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  K. Maclennan,et al.  The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  R N Hoover,et al.  Risk of leukemia after chemotherapy and radiation treatment for breast cancer. , 1992, The New England journal of medicine.

[11]  H. Rockette,et al.  Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.